A Randomized Trial in Healthy Subjects to Assess the Bioequivalence of an Atazanavir/Cobicistat Fixed-Dose Combination Tablet versus Administration as Separate Agents - Concepedia

Concepedia

Publication | Closed Access

A Randomized Trial in Healthy Subjects to Assess the Bioequivalence of an Atazanavir/Cobicistat Fixed-Dose Combination Tablet versus Administration as Separate Agents

13

Citations

14

References

2014

Year

Heather Sevinsky, Xiaolu Tao, Reena Wang, Palanikumar Ravindran, Karen Sims, Xiaohui Xu, Navin Jariwala, Richard Bertz

Antiviral Therapy

Abstract

ATV/COBI (300/150 mg) FDC tablet was bioequivalent to coadministration as separate agents with a light meal in healthy subjects. Clinicaltrials.gov identifier NCT01837719.

References

	Year	Citations

Page 1